e-learning
resources
Paris 2018
Monday, 17.09.2018
Clinical management of pleural malignancies, including mesothelioma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study
I. Novakov (Plovdiv, Bulgaria), F. Sterev (Plovdiv, Bulgaria)
Source:
International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Session:
Clinical management of pleural malignancies, including mesothelioma
Session type:
Thematic Poster
Number:
2890
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Novakov (Plovdiv, Bulgaria), F. Sterev (Plovdiv, Bulgaria). Survival of patients with malignant pleural effusions: a three-year prospective self-experience study. 2890
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience.
Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Year: 2020
LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Parapneumonic effusions and empyema in childhood: a retrospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 319s
Year: 2003
Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004
Survival time in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010
Pediatric pleural effusions: a retrospective review of 492 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 311s
Year: 2006
Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
Belgian prospective, multicenter, observational study of patients with malignant pleural mesothelioma treated with pemetrexed plus platinum
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Diagnostic value of medical thoracoscopy in pleural disease – a 5-year retrospective study
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
Talc pleurodesis in malignant pleural effusions: A 5-year experience
Source: Annual Congress 2012 - Medical access to the pleura
Year: 2012
Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009
Real life diagnosis in pleural effusion: a retrospective survey
Source: Eur Respir J 2006; 28: Suppl. 50, 580s
Year: 2006
Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019
A prospective study on etiology of haemorrhagic pleural effusion
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
Resolution of tuberculosis pleural effusions following anti-tuberculosis treatment alone – a retrospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 419s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept